Skip to content

Drug interactions

Modafinil + Pacritinib

Severity: Moderate

Modafinil and Pacritinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pacritinib is a CYP3A4 substrate, and modafinil is a weak-to-moderate CYP3A4 inducer. Reduced pacritinib concentrations may lessen its efficacy in myelofibrosis.

What this interaction means in plain words

Modafinil and Pacritinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Modafinil belongs to Central Nervous System; Pacritinib belongs to Oncology.

Evidence level: Low

Why it happens

Modafinil induces CYP3A4, increasing pacritinib metabolism and lowering exposure.

What to do

Monitor spleen response and blood counts, and consider an alternative to modafinil if efficacy declines. Avoid strong inducers with pacritinib.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Modafinil and Pacritinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Modafinil with Pacritinib?

MediHelp rates the interaction as moderate. Modafinil and Pacritinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pacritinib is a CYP3A4 substrate, and modafinil is a weak-to-moderate CYP3A4 inducer. Reduced pacritinib concentrations may lessen its efficacy in myelofibrosis.

How serious is the interaction between Modafinil and Pacritinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor spleen response and blood counts, and consider an alternative to modafinil if efficacy declines. Avoid strong inducers with pacritinib.

What other medicines interact with Modafinil?

MediHelp also lists interactions of Modafinil with, for example, Lenacapavir, Leniolisib, Lorlatinib. The full list is on the Modafinil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in